[CD16+ CD56- indolent, NK cell-lineage granular lymphocyte proliferative disorder with autoimmune hemolytic anemia]

N Tomita1, S Motomura, S Takemura

  • 1Department of Hematology, Yokohama City University Medical Center.

Insights

This rare case highlights a patient with natural killer cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) and autoimmune hemolytic anemia (AIHA). Methylprednisolone showed transient effectiveness in managing both conditions.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Natural killer cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) is a rare hematologic malignancy.
  • Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies against red blood cells.
  • The co-occurrence of NK-GLPD and AIHA is exceptionally uncommon.

Observation:

  • A 64-year-old male presented with CD16+ CD56- NK-GLPD and Coombs-negative AIHA.
  • Initial treatment with intravenous methylprednisolone (1,000 mg for 3 days) provided temporary relief for both conditions.
  • Recurrence of AIHA was accompanied by a reappearance of NK-GLPD.

Findings:

  • The patient's NK-GLPD and AIHA demonstrated a parallel clinical course.
  • Repeated methylprednisolone treatment effectively controlled both the hematologic malignancy and the autoimmune anemia.

Implications:

  • This case underscores the potential link between NK-GLPD and autoimmune phenomena.
  • It suggests that methylprednisolone may be a viable therapeutic option for managing concurrent NK-GLPD and AIHA.
  • Further research is warranted to elucidate the pathogenetic mechanisms underlying this rare association.